EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Greenway Greenhouse Cannabis EBITDA Margin % Related Terms
Greenway Greenhouse Cannabis EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Greenway Greenhouse Cannabis's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenway Greenhouse Cannabis EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Greenway Greenhouse Cannabis's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Greenway Greenhouse Cannabis's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Greenway Greenhouse Cannabis (GWAYF) has a EBITDA Margin % of 23.72% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Greenway Greenhouse Cannabis and its competitors. According to the industry distribution chart, Greenway Greenhouse Cannabis ranks #118 out of 952 companies in the Drug Manufacturers industry, placing it in the top 12.4%.
Is Greenway Greenhouse Cannabis' EBITDA Margin % too high?
Greenway Greenhouse Cannabis' current EBITDA Margin % is 23.72%. The Drug Manufacturers industry median EBITDA Margin % is 12.47. Greenway Greenhouse Cannabis' value of 23.72% is 90.2% above this industry median. Based on the distribution chart, Greenway Greenhouse Cannabis ranks #118 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Greenway Greenhouse Cannabis has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Greenway Greenhouse Cannabis' EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Greenway Greenhouse Cannabis ranks #118 out of 952 companies for EBITDA Margin %. This places Greenway Greenhouse Cannabis in the top 12% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 12.47. Greenway Greenhouse Cannabis' value of 23.72% is 90.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Greenway Greenhouse Cannabis's current EBITDA Margin % of 23.72% is 90.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Greenway Greenhouse Cannabis and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greenway Greenhouse Cannabis's current EBITDA Margin % is 23.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.28, compared to a current price of $0.10 — trading 63.6% below its estimated fair value. The current EBITDA Margin % is 23.72% and 90.2% above the Drug Manufacturers industry median of 12.47. Greenway Greenhouse Cannabis' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current EBITDA Margin % is 23.72% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Greenway Greenhouse Cannabis (GWAYF) Overvalued in 2026?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis stock appears to be undervalued.
The current stock price of $0.10 is trading 63.6% below its estimated GF Value™ of $0.28.
GuruFocus considers Greenway Greenhouse Cannabis to be Possible Value Trap.
Key valuation signals for GWAYF:
EBITDA Margin %: 23.72%
GF Value™: $0.28 vs. price of $0.10 (63.6% below fair value)
Industry Position: 90.2% above the Drug Manufacturers median (#118 of 952)
No single metric tells the full story. See the GWAYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.
24GF Score
Get the complete analysis for GWAYF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GWAYF has been successfully added to your 
